Skip to main content
Fig. 1 | BMC Cancer

Fig. 1

From: HLA class II molecule HLA-DRA identifies immuno-hot tumors and predicts the therapeutic response to anti-PD-1 immunotherapy in NSCLC

Fig. 1

Screening potential biomarkers for immunotherapy in NSCLC. A Heatmap of DEGs between samples from responders and non-responders in the GSE126044 dataset. B Heatmap of DEGs between samples from responders and non-responders in the GSE13522 dataset. C Heatmap of DEGs between samples from responders and non-responders in the GSE136961 dataset. D The intersection of DEGs in GSE126044, GSE13522, and GSE136961 datasets. E BP analysis of intersected genes in these three GEO datasets. “Count” represents the number of 7 candidates

Back to article page